BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37782469)

  • 1. The burden of nonalcoholic fatty liver disease (NAFLD) is rapidly growing in every region of the world from 1990 to 2019.
    Paik JM; Henry L; Younossi Y; Ong J; Alqahtani S; Younossi ZM
    Hepatol Commun; 2023 Oct; 7(10):. PubMed ID: 37782469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Burden of non-alcoholic fatty liver disease in Asia, the Middle East and North Africa: Data from Global Burden of Disease 2009-2019.
    Golabi P; Paik JM; AlQahtani S; Younossi Y; Tuncer G; Younossi ZM
    J Hepatol; 2021 Oct; 75(4):795-809. PubMed ID: 34081959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Global, Regional, and National Burden and Trends of NAFLD in 204 Countries and Territories: An Analysis From Global Burden of Disease 2019.
    Chen H; Zhan Y; Zhang J; Cheng S; Zhou Y; Chen L; Zeng Z
    JMIR Public Health Surveill; 2022 Dec; 8(12):e34809. PubMed ID: 36508249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 Cirrhosis Collaborators
    Lancet Gastroenterol Hepatol; 2020 Mar; 5(3):245-266. PubMed ID: 31981519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global burden of NAFLD and chronic liver disease among adolescents and young adults.
    Paik JM; Kabbara K; Eberly KE; Younossi Y; Henry L; Younossi ZM
    Hepatology; 2022 May; 75(5):1204-1217. PubMed ID: 34741554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence trends in non-alcoholic fatty liver disease at the global, regional and national levels, 1990-2017: a population-based observational study.
    Ge X; Zheng L; Wang M; Du Y; Jiang J
    BMJ Open; 2020 Aug; 10(8):e036663. PubMed ID: 32747349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 Risk Factor Collaborators
    Lancet; 2018 Nov; 392(10159):1923-1994. PubMed ID: 30496105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global Burden of Nonalcoholic Fatty Liver Disease, 1990 to 2019: Findings From the Global Burden of Disease Study 2019.
    Jiang W; Mao X; Liu Z; Zhang T; Jin L; Chen X
    J Clin Gastroenterol; 2023 Jul; 57(6):631-639. PubMed ID: 35921320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in the Global Burden of Chronic Liver Diseases From 2012 to 2017: The Growing Impact of NAFLD.
    Paik JM; Golabi P; Younossi Y; Mishra A; Younossi ZM
    Hepatology; 2020 Nov; 72(5):1605-1616. PubMed ID: 32043613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and Patient-Reported Outcomes From Patients With Nonalcoholic Fatty Liver Disease Across the World: Data From the Global Non-Alcoholic Steatohepatitis (NASH)/ Non-Alcoholic Fatty Liver Disease (NAFLD) Registry.
    Younossi ZM; Yilmaz Y; Yu ML; Wai-Sun Wong V; Fernandez MC; Isakov VA; Duseja AK; Mendez-Sanchez N; Eguchi Y; Bugianesi E; Burra P; George J; Fan JG; Papatheodoridis GV; Chan WK; Alswat K; Saeed HS; Singal AK; Romero-Gomez M; Gordon SC; Roberts SK; El Kassas M; Kugelmas M; Ong JP; Alqahtani S; Ziayee M; Lam B; Younossi I; Racila A; Henry L; Stepanova M;
    Clin Gastroenterol Hepatol; 2022 Oct; 20(10):2296-2306.e6. PubMed ID: 34768009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The silent burden of non-alcoholic fatty liver disease in the elderly: A global burden of disease analysis.
    Danpanichkul P; Ng CH; Muthiah MD; Duangsonk K; Yong JN; Tan DJH; Lim WH; Wong ZY; Syn N; Tsusumi T; Takahashi H; Siddiqui MS; Wong VW; Mantzoros CS; Huang DQ; Noureddin M; Loomba R; Sanyal AJ; Wijarnpreecha K
    Aliment Pharmacol Ther; 2023 Nov; 58(10):1062-1074. PubMed ID: 37694808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global burden of primary liver cancer and its association with underlying aetiologies, sociodemographic status, and sex differences from 1990-2019: A DALY-based analysis of the Global Burden of Disease 2019 study.
    Choi S; Kim BK; Yon DK; Lee SW; Lee HG; Chang HH; Park S; Koyanagi A; Jacob L; Dragioti E; Radua J; Shin JI; Kim SU; Smith L
    Clin Mol Hepatol; 2023 Apr; 29(2):433-452. PubMed ID: 36597018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global burden of non-alcoholic fatty liver disease in 204 countries and territories from 1990 to 2019.
    Tian H; Zhang K; Hui Z; Ren F; Ma Y; Han F; Sun X; Kan C; Hou N
    Clin Res Hepatol Gastroenterol; 2023 Jan; 47(1):102068. PubMed ID: 36513252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in the global, regional, and national burdens of NAFLD from 1990 to 2019: A systematic analysis of the global burden of disease study 2019.
    Wang D; Xu Y; Zhu Z; Li Y; Li X; Li Y; Shen H; Wu W; Liu Y; Han C
    Front Nutr; 2022; 9():1047129. PubMed ID: 36618688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Burden of liver complications related to non-alcoholic fatty liver disease in China from 2005 to 2019: Observations from the Global Burden of Disease Study, 2019.
    Liu H; Qi J; Yang J; Liu F; Li X; Yin P; Wang L; Liang Z; Wei L; Rao H; Zhou M
    Diabetes Obes Metab; 2023 Apr; 25 Suppl 1():43-52. PubMed ID: 36781698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing prevalence of NAFLD/NASH among children, adolescents and young adults from 1990 to 2017: a population-based observational study.
    Zhang X; Wu M; Liu Z; Yuan H; Wu X; Shi T; Chen X; Zhang T
    BMJ Open; 2021 May; 11(5):e042843. PubMed ID: 33947727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950-2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019.
    GBD 2019 Demographics Collaborators
    Lancet; 2020 Oct; 396(10258):1160-1203. PubMed ID: 33069325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global burden of cirrhosis and other chronic liver diseases due to nonalcoholic fatty liver disease, 1990-2019.
    Liu ZP; Ouyang GQ; Huang GZ; Wei J; Dai L; He SQ; Yuan GD
    World J Hepatol; 2023 Nov; 15(11):1210-1225. PubMed ID: 38075011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global trends and regional differences in disease burden of stroke among children: a trend analysis based on the global burden of disease study 2019.
    Du M; Mi D; Liu M; Liu J
    BMC Public Health; 2023 Oct; 23(1):2120. PubMed ID: 37891500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review.
    Younossi ZM; Golabi P; Paik JM; Henry A; Van Dongen C; Henry L
    Hepatology; 2023 Apr; 77(4):1335-1347. PubMed ID: 36626630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.